Sterol 27-hydroxylase: Expression in human arterial endothelium

Journal of Lipid Research

Volumn 38, Issue 6, 1997, Pages 1254-1260

  Reiss, Allison B ^a   Martin, Kumiko O ^a   Rojer, David E ^a   Iyer, Shilesh ^a   Grossi, Eugene A ^a   Galloway, Aubrey C ^a   Javitt, Norman B ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

27 hydroxycholesterol; 3 hydroxy 5 cholesterenoic acid; Cholesterol metabolism; Human aortic endothelial cells; Human pulmonary artery endothelial cells; RT PCR

Indexed keywords

CHOLESTEROL DERIVATIVE; OXYGENASE;

ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; BILE ACID SYNTHESIS; CHOLESTEROL METABOLISM; ENZYME METABOLISM; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROXYLATION; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; STEROL METABOLISM; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

AORTA; BASE SEQUENCE; BLOTTING, NORTHERN; CELLS, CULTURED; CHOLESTEROL; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PULMONARY ARTERY; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 0030952498     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cali, J. J., and D.W. Russell, 1991. Characterization of human sterol 27-hydroxylase. J. Biol. Chem. 266: 7774-7778.
2. Sato, R., Y. Atsuta, S. Imai, S. Taniguchi, and K. Okuda. 1977. Hepatic mitochondrial cytochrome P-450: isolation and functional characterization. Proc. Natl. Acad. Sci. USA. 74: 5477-5481.
3. Andersson, S., D. L. Davis, H. Dahlbäck, H. Jornvall, and D.W. Russell, 1989. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264: 8222-8229.
4. Reiss, A. B., K. O. Martin, N. B. Javitt, D. W. Martin, E. A. Grossi, and A. C. Galloway. 1994. Sterol 27-hydroxylase: high levels of activity in vascular endothelium. J. Lipid Res. 35: 1026-1030.
5. Watkins, M. T., J. B. Sharefkin, R. Zajtchuk, T. M. Maciag, P. A. D'Amore, U. S. Ryan, H. Van Wart, and N. M. Rich. 1984. Adult human saphenous vein endothelial cells: assessment of their reproductive capacity for use in endothelial seeding of vascular prostheses. J. Surg. Res. 36: 588-596.
6. DeCaprio, J., J. Yun, and N. B. Javitt. 1992. Bile acid and sterol solubilization in 2-hydroxypropyl-β-cyclodextrin. J. Lipid Res. 33: 441-443.
7. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86: 9717-9721.
8. Scheuermann R. H., and S. R. Bauer. 1993. Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression. Methods Enzymol. 218: 446-473.
9. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol Biol. 215: 403-410.
10. Leitersdorf, E., A. Reshef, V. Meiner, R. Levitzki, S. Schwartz, E. Dann, N. Berkman, J. Cali, L. Klapholz, and V. Berginer. 1993. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin. J. Clin. Invest. 91: 2488-2496.
11. Martin, K. O., K. Budai, and N. B. Javitt. 1993. Cholesterol and 27-hydroxycholesterol 7α-hydroxylation: evidence for two different enzymes. J. Lipid Res. 34: 581-588.
12. Cali J. J., C. Hsieh, U. Francke, and D. W. Russell. 1991. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 266: 7779-7783.
13. Bergström, S. 1959. Bile acids formation and metabolism. In Ciba Foundation Symposium on the Biosynthesis of Terpenes and Sterols. G.E.W. Wolstenholme, and M. O'Connor, editors, Little Brown & Co, Boston. 185-203.
14. Kudo K., G. T. Emmons, E. W. Casserly, D. P. Via, L. C. Smith, J. S. Pyrek and G. J. Schroepfer, Jr. 1989. Chromatography of acetate derivatives of oxygenated sterols. J. Lipid Res. 30: 1097-1111.
15. Björkem, I., O. Andersson, U. Diczfalusy, B. Sevastik, and R. Xiu. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592-8596.
16. Stocco, D. M., and B. J. Clark. 1996. Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem. Pharmacol. 51: 197-205.
17. Waterman, M. R. 1995. A rising StAR: an essential role in cholesterol transport. Science. 267: 1780-1781.
18. Sugawara T., D. Lin, J. A. Holt, K. O. Martin, N. B. Javitt, W. L. Miller, and J. F. Strauss III. 1995. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry. 34: 12506-12512.
19. Oftebro, H., I. Björkhem, S. Skrede, A. Shreiner, and J. I. Pedersen. 1980. Cerebrotendinous xanthomatosis. J. Clin. Invest. 65: 1418-1430.
20. Fujiyama, J., M. Kuriyama, S. Arima, Y. Shibata, K. Nagata, S. Takenaga, H. Tanaka, and M. Osame. 1991. Atherogenic risk factors in cerebrotendinous xanthomatosis. Clin. Chim. Acta. 200: 1-12.
21. Salen, G., T.W. Meriwether, and G. Nicolav. 1975. Chenodeoxycholic acid inhibits increased cholesterol and cholesterol synthesis in patients with cerebrotendinous xanthomatosis. Biochem. Med. 14: 57-74.
22. Berginer, V.M., G. Salen, and S. Shefer. 1984. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N. Engl. J. Med. 311: 1649-1652.
23. Chang, W.N., M. Kuriyama, and E. Chee. 1994. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings. J. Formos. Med. Assoc. 93: 256-259.
24. Donaghy, M., R.H.M. King, R.O. McKeran, M.S. Schwartz, and P.K. Thomas. 1990. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid. J. Neurol. 237: 216-219.